Charles River - JP Morgan Conference Presentation
Manufacturing Solutions Segment
Safe production and release of manufactured products
-
Microbial Solutions
Rapid, efficient testing platform for
microbial detection and
identification of sterile and non-
sterile applications
•
•
•
Leading global provider of
quality-control (QC) testing
products and services
FDA-mandated lot release
testing for sterile
biopharmaceutical products
Market-leading platforms
EndosafeⓇ endotoxin
detection
AccugenixⓇ microbial
identification and strain typing
CelsisⓇ rapid microbial
detection
-
Biologics Testing
Process development and quality-
control testing to support the
manufacture of biologics
Premier global partner in
navigating the complex
pathway to biologic
effectiveness
Supports developers and
manufacturers with their
testing, characterization,
and cell bank manufacturing
needs
Testing and assay
development throughout drug
development, clinical and
commercial manufacturing
-
i
C> CDMO
Scientific partner for cell and gene
therapy development, testing, and
manufacturing
Solutions across all major
CDMO platforms for C>
Primary expertise in gene-
modified cell therapy with
growing capabilities in gene
therapy, including plasma DNA
and viral vectors
Excellent strategic fit across
CRL portfolio
Integrated value chain from
foundational cellular materials
through analytical testing and
the production of advanced
therapies
~70%
Microbial revenue from
reagents/consumables, creating
a recurring revenue stream
~70%
Cell Therapy
CDMO Revenue Mix
by Service Area
Hannah
~20%
Viral Vector
-10%
54
charles rive
Plasmid DNA
Charles River - JP Morgan Conference Presentation
14View entire presentation